Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study

被引:18
|
作者
Larsen, Rikke Faebo [1 ,2 ,3 ]
Jarden, Mary [4 ,5 ]
Minet, Lisbeth Rosenbek [2 ,6 ,7 ]
Frolund, Ulf Christian [8 ]
Moeller, Soeren [2 ]
Abildgaard, Niels [2 ,9 ,10 ]
机构
[1] Zealand Univ Hosp, Dept Physiotherapy & Occupat Therapy, Roskilde, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Odense Univ Hosp, OPEN, Open Patient Data Explorat Network, Odense, Denmark
[4] Copenhagen Univ Hosp, Dept Haematol, Rigshosp, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark
[6] Odense Univ Hosp, Dept Rehabil, Odense, Denmark
[7] UCL Univ Coll, Hlth Sci Res Ctr, Odense, Denmark
[8] Zealand Univ Hosp, Dept Haematol, Roskilde, Denmark
[9] Odense Univ Hosp, Dept Haematol, Odense, Denmark
[10] Odense Univ Hosp, Acad Geriatr Canc Res AgeCare, Odense, Denmark
关键词
Multiple myeloma; Bone disease; Physical function; Reference values; Cross sectional; QUALITY-OF-LIFE; ANDROGEN-DEPRIVATION THERAPY; MUSCLE STRENGTH; OLDER-ADULTS; WALK TEST; EXERCISE; CANCER; FITNESS; VALIDITY; CHEMOTHERAPY;
D O I
10.1186/s12885-020-6637-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMultiple myeloma is a cancer in the bone marrow causing bone destruction. Patients experience various symptoms related to the disease and/or treatment, such as pain and fatigue, leading to poorer quality of life. The symptom burden might affect physical function and physical activity levels, posing a risk of physical deterioration. The aim was to investigate whether physical function in newly diagnosed patients with multiple myeloma differs from the reference values of the normal population and other cancer patients.MethodsThe study is a cross sectional descriptive analysis of a prospective cohort of 100 patients newly diagnosed with multiple myeloma. Four physical function tests were carried out; Six-Minute-Walk-Test, Sit-to-Stand-Test, grip strength and knee extension strength. Age and gender specific results of physical function from the multiple myeloma population were compared to normative data and to data from other cancer populations.ResultsOf the 100 patients included, 73% had bone disease and 55% received pain relieving medicine. Mean age was 67.7years (SD 10.3). Patients with multiple myeloma had significantly poorer physical function compared to normative data, both regarding aerobic capacity and muscle strength, although not grip strength. No differences in physical function were found between patients with multiple myeloma and other cancer populations.ConclusionsPhysical function in newly diagnosed Danish patients with multiple myeloma is lower than in the normal population. Exercise intervention studies are warranted to explore the value of physical exercise on physical function.Trial registrationClinicalTrials.gov, ID NCT02439112, registered 8 May 2015.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
    Rikke Faebo Larsen
    Mary Jarden
    Lisbeth Rosenbek Minet
    Ulf Christian Frølund
    Sören Möller
    Niels Abildgaard
    BMC Cancer, 20
  • [2] Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study
    Sorrig, Rasmus
    Klausen, Tobias W.
    Salomo, Morten
    Vangsted, Annette
    Gimsing, Peter
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (02) : 182 - 190
  • [3] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [4] A pilot study of physical activity in newly diagnosed elderly patients with multiple myeloma.
    Binder, Adam F.
    Spinelli, Bryan
    Melillo, Rebecca
    Crane, Nicole
    D'Adamo, Laura
    Martinelli, Mary K.
    Martinez-Outschoorn, Ubaldo
    Butryn, Meghan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [6] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [7] Application of the IMWG Frailty Score in Newly Diagnosed Multiple Myeloma Patients in a Brazilian Cohort
    Santos, Valeria Vianna
    Pessoa de Magalhaes Filho, Roberto Jose
    Cibreiros, Mariana
    Marcal, Mariana
    Vasconcellos, Liz
    de Castro, Marcella Gil
    de Albuquerque, Juliano
    Maiolino, Angelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S129 - S130
  • [8] Management of Newly Diagnosed Elderly Multiple Myeloma Patients
    Crystal Antoine-Pepeljugoski
    Marc Justin Braunstein
    Current Oncology Reports, 2019, 21
  • [9] Experimental Characteristics of Patients with Newly Diagnosed Multiple Myeloma
    Li, Linzhang
    Han, Chengwu
    Yu, Xueying
    Cai, Ying
    Cao, Yongyue
    Shen, Jun
    Cao, Yongtong
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (08) : 529 - 533
  • [10] Peripheral neuropathy in newly diagnosed multiple myeloma patients
    Ballegaard, Martin
    Gimsing, Peter
    NEUROLOGY, 2008, 70 (11) : A366 - A367